In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine prevention.

Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies.

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, Ocugen, and Pfizer.

Annual Meeting Clinical Trials Plenary Session, Sanofi presented data on tolebrutinib in patients with non-relapsing ...

LifeMine Therapeutics has dosed the first subject in the Phase I trial of calcineurin inhibitor (CNi), LIFE-001.

MaaT Pharma has reported positive results from an interim safety analysis of its Phase IIb trial of MaaT033 in subjects ...

Scientist.com has launched a new tool, Clinical Labs Navigator, for sourcing, managing, and executing services for clinical ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

Apnimed has dosed the first subject in the Phase IIA RESTEADY trial of SASS-001, an oral drug combo for sleep apnoea with a ...

The FDA has granted clearance to CureVac's IND for the open-label Phase I trial of CVHNLC in individuals with sqNSCLC.